Cat. No.: X24-08-YM249
Microtubule/Tubulin inhibitor, VCP-Eribulin, Purity ≥98%
Synonym: 2130869-17-7; HY-128871; CS-0101613; [4-[[(2S)-2-[[(2S)-2-Amino-3-methylbutanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]phenyl]methyl N-[(2S)-2-hydroxy-3-[(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-21-methoxy-14-methyl-8,15-dimethylidene-24-oxo-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-20-yl]propyl]carbamate
- CAS Number: 2130869-17-7
- Compound CID: 138911393
Product Size
1 mg; 2 mg; 5 mg; 10 mg
Properties
Description
VCP-Eribulin is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin.
Molecular Formula
C59H86N6O16
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
VCP-Eribulin is a cytoskeletal signaling inhibitor that can be used for its ability to enhance targeted delivery to cancer cells.
Storage
Store at -20ºC, and keep desiccated.
Related Products
- Microtubule/Tubulin inhibitor, Monomethyl auristatin E, Purity ≥98%
- Microtubule/Tubulin inhibitor, ABT-751, Purity ≥98%
- Microtubule/Tubulin inhibitor, Albendazole, Purity ≥98%
- Microtubule/Tubulin inhibitor, Chloroxine, Purity ≥98%
- Microtubule/Tubulin inhibitor, CYT997, Purity ≥98%
- Microtubule/Tubulin inhibitor, Epothilone A, Purity ≥98%